Literature DB >> 2301480

Changes in uterine blood flow during human pregnancy.

I Thaler1, D Manor, J Itskovitz, S Rottem, N Levit, I Timor-Tritsch, J M Brandes.   

Abstract

A transvaginal duplex Doppler ultrasonography system was used to measure blood flow characteristics in the ascending uterine artery before and during pregnancy. The system uses a 5 MHz Doppler transducer coupled to a 6.5 MHz imaging probe. There was a steady increase in volume flow rate in the left ascending uterine artery from a mean of 94.5 ml/min before pregnancy to a mean of 342 ml/min in late gestation (reflecting a 3.5-fold increase). With the assumption of equal flow on both uterine arteries, the fraction of the cardiac output that is distributed to these vessels was calculated to be 3.5% in early pregnancy and to reach 12% near term. The mean diameter of this vessel in the nonpregnant state was 1.6 mm, increasing to 3.7 mm toward term. The resistance to flow, expressed as the peak systolic to end-diastolic flow velocity ratio, declined from a mean of 5.3 in the nonpregnant state to a mean of 2.3 near term. These changes reflect the perpetual growth and development of the uteroplacental circulation, which provides the metabolic demands of the growing fetus throughout gestation.

Entities:  

Mesh:

Year:  1990        PMID: 2301480     DOI: 10.1016/0002-9378(90)90834-t

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  46 in total

Review 1.  Uteroplacental blood flow. The story of decidualization, menstruation, and trophoblast invasion.

Authors:  H J Kliman
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

2.  Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.

Authors:  Khaled Abduljalil; Penny Furness; Trevor N Johnson; Amin Rostami-Hodjegan; Hora Soltani
Journal:  Clin Pharmacokinet       Date:  2012-06-01       Impact factor: 6.447

3.  Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1.

Authors:  Ori Nevo; Nima Soleymanlou; Yuan Wu; Jing Xu; John Kingdom; Ariel Many; Stacy Zamudio; Isabella Caniggia
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-04-20       Impact factor: 3.619

4.  A novel three-dimensional in vitro system to study trophoblast-endothelium cell interactions.

Authors:  Paulomi B Aldo; Graciela Krikun; Irene Visintin; Charles Lockwood; Roberto Romero; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2007-08       Impact factor: 3.886

Review 5.  Trophoblast-mediated spiral artery remodelling: a role for apoptosis.

Authors:  Guy St J Whitley; Judith E Cartwright
Journal:  J Anat       Date:  2009-02-09       Impact factor: 2.610

Review 6.  Basic principles and clinical applications of the transvaginal Doppler duplex system in reproductive medicine.

Authors:  I Thaler; D Manor; J Brandes; S Rottem; J Itskovitz
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-04

7.  Vascular smooth muscle cells during spiral artery remodeling in early human pregnancy†.

Authors:  Dong-Bao Chen; Ronald R Magness
Journal:  Biol Reprod       Date:  2021-02-11       Impact factor: 4.285

Review 8.  Animal Models to Study Placental Development and Function throughout Normal and Dysfunctional Human Pregnancy.

Authors:  Peta L Grigsby
Journal:  Semin Reprod Med       Date:  2016-01-11       Impact factor: 1.303

9.  Low-Dose Aspirin and Sporadic Anovulation in the EAGeR Randomized Trial.

Authors:  Rose G Radin; Lindsey A Sjaarda; Neil J Perkins; Robert M Silver; Zhen Chen; Laurie L Lesher; Noya Galai; Jean Wactawski-Wende; Sunni L Mumford; Enrique F Schisterman
Journal:  J Clin Endocrinol Metab       Date:  2017-01-01       Impact factor: 5.958

Review 10.  Matrix metalloproteinases as drug targets in preeclampsia.

Authors:  Ana C T Palei; Joey P Granger; Jose E Tanus-Santos
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.